Ikarian Capital, LLC Soleno Therapeutics Inc Transaction History
Ikarian Capital, LLC
- $573 Million
- Q3 2024
Shares
6 transactions
About SOLENO THERAPEUTICS INC
- Ticker SLNO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,101,250
- Market Cap $362M
- Description
- Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...